American Gastroenterological Association Institute Technical Review on the Use of Thiopurines, Methotrexate, and Anti-TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease

被引：98
作者：
Dassopoulos, Themistocles [1 ]
Sultan, Shahnaz [2 ]
Falck-Ytter, Yngve T. [3 ]
Inadomi, John M. [4 ]
Hanauer, Stephen B. [5 ]
机构：
[1] Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA
[2] Univ Florida, Coll Med, Div Gastroenterol Hepatol & Nutr, Malcom Randall VA Med Ctr, Gainesville, FL USA
[3] Case Western Reserve Univ, Case & VA Med Ctr, Div Gastroenterol, Cleveland, OH 44106 USA
[4] Univ Washington, Sch Med, Div Gastroenterol, Seattle, WA USA
[5] Univ Chicago, Sect Gastroenterol & Nutr, Chicago, IL 60637 USA
来源：
GASTROENTEROLOGY | 2013年 / 145卷 / 06期
关键词：
ANTITUMOR NECROSIS FACTOR; CERTOLIZUMAB PEGOL CDP870; PEGYLATED FAB FRAGMENT; BOWEL-DISEASE; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; DOSE INTENSIFICATION; COMBINATION THERAPY; ULCERATIVE-COLITIS; WITHDRAWAL TRIAL;
D O I：
10.1053/j.gastro.2013.10.046
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1464 / +
页数：20
相关论文
共 70 条
[1]  
Aaltonen KJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030275, 10.1371/journal.pone.0043508]
[2]   Methotrexate for induction of remission in refractory Crohn's disease [J].
Alfadhli, AAF ;
McDonald, JWD ;
Feagan, BG .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01)
[3]  
[Anonymous], The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta- Analysis
[4]  
[Anonymous], REV MAN REVMAN COMP
[5]   Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study [J].
Ardizzone, S ;
Bollani, S ;
Manzionna, G ;
Imbesi, V ;
Colombo, E ;
Porro, GB .
DIGESTIVE AND LIVER DISEASE, 2003, 35 (09) :619-627
[6]   Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study [J].
Beaugerie, Laurent ;
Brousse, Nicole ;
Bouvier, Anne Marie ;
Colombel, Jean Frederic ;
Lemann, Marc ;
Cosnes, Jacques ;
Hebuterne, Xavier ;
Cortot, Antoine ;
Bouhnik, Yoram ;
Gendre, Jean Pierre ;
Simon, Tabassome ;
Maynadie, Marc ;
Hermine, Olivier ;
Faivre, Jean ;
Carrat, Fabrice .
LANCET, 2009, 374 (9701) :1617-1625
[7]   Loss of Response and Need for Adalimumab Dose Intensification in Crohn's Disease: A Systematic Review [J].
Billioud, Vincent ;
Sandborn, William J. ;
Peyrin-Biroulet, Laurent .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04) :674-684
[8]   A PEGylated Fab' fragment against tumor necrosis factor for the treatment of Crohn disease - Exploring a new mechanism of action [J].
Bourne, Tim ;
Fossati, Gianluca ;
Nesbitt, Andrew .
BIODRUGS, 2008, 22 (05) :331-337
[9]   Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease [J].
Burmester, Gerd R. ;
Panaccione, Remo ;
Gordon, Kenneth B. ;
McIlraith, Melissa J. ;
Lacerda, Ana P. M. .
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (04) :517-524
[10]   A CONTROLLED DOUBLE-BLIND-STUDY OF AZATHIOPRINE IN THE MANAGEMENT OF CROHNS-DISEASE [J].
CANDY, S ;
WRIGHT, J ;
GERBER, M ;
ADAMS, G ;
GERIG, M ;
GOODMAN, R .
GUT, 1995, 37 (05) :674-678
1234567